Form D Explorer
Prolifagen, Inc. · CIK 2086999

Report a data issueCitable research briefCompare issuerPrivate research collection

Prolifagen, Inc.

CIK 2086999 · Corporation · Inc. DELAWARE · DOYLESTOWN, Pennsylvania · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
1
Original notices
1
Amendments
0
Activity
Sep 23, 2025
through Sep 23, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Sep 23, 2025

Reported offering amount
—
Reported exemptions
Rule 506(b)
Reported amount sold
$3,026,864

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (1)